Curated summary · agent-written · kb/genes/curated/hgnc_10606.md
All 11 claims checked against the KB draft

SCP2 across dismech

SCP2 (sterol carrier protein 2) is named by 1 disorder entry. The locus encodes two proteins, the peroxisomal thiolase SCPx and the lipid-transfer protein SCP2.

Normal function

ai-gene-review gives two core molecular functions, one per product: cholesterol transfer activity; and propionyl-CoA C2-trimethyltridecanoyltransferase activity, acting in bile acid biosynthetic process; fatty acid beta-oxidation; and sterol transport.

Disease records

The one entry types SCP2 as causative: Sterol Carrier Protein 2 Deficiency, with a germline variant origin and a functional impact of loss of function. SCP2 sits on the node SCPx Loss of Function, which carries the thiolase activity as its lost molecular function. ClinGen rates the relationship definitive.

Where the layers agree and disagree

The KB places the thiolase on the SCP2 node and the beta-oxidation and bile-acid processes on downstream nodes that do not name the gene, so the exact-identifier overlap between KB processes on SCP2's own nodes and ai-gene-review core processes is 0.

Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.

Normal function · from ai-gene-review (P22307, commit 79fe13b38970) · AI-generated, not KB evidence

ai-gene-review has this gene at status INITIALIZED; the description is shown only once the review is complete. Read the draft upstream.

In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Sterol Carrier Protein 2 Deficiency causative germline loss of function
CLINGEN: definitive
mechanism: SCPx Loss of Function
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
sterol carrier protein 2 deficiency MONDO:0013391 AR Definitive
2025-02-21
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.